PRMT1 and Miyoshi myopathy: Together, these data highlight the broad impact of PRMT1 inhibition in MM cells, likely driven by its ability to methylate arginine residues on both histone and non-histone proteins, thereby influencing gene expression through chromatin remodeling and regulating essential processes such as transcription, DNA damage response, and cell signaling.